Literature DB >> 32543073

How I investigate neutropenia.

John L Frater1.   

Abstract

Neutropenia is a common laboratory finding in adults and children. Its underlying causes are extremely heterogeneous and include benign conditions, autoimmune disorders, infections, and malignancies. The clinical laboratory plays a central role in the diagnosis of these disorders, including data derived from hematology, microbiology, molecular biology/cytogenetics, and clinical chemistry. The purpose of this review is to (a) highlight the clinical, hematologic, and molecular genetic features of the major entities resulting in neutropenia and (b) outline an algorithm-based approach to permit the classification of neutropenias.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  neutropenia; neutrophils

Year:  2020        PMID: 32543073     DOI: 10.1111/ijlh.13210

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  4 in total

1.  Diagnosis and therapeutic decision-making for the neutropenic patient.

Authors:  James A Connelly; Kelly Walkovich
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

2.  The Prevalence of Isolated Neutropenia at High Altitude in Southern Saudi Arabia: Does Altitude Affect Leucocyte Count?

Authors:  Husain Y Alkhaldy; Zuhier A Awan; Ahmed A Abouzaid; Hossameldin M Elbahaie; Saeed M Al Amoudi; Mohamed Andarawi; Shehata F Shehata
Journal:  Int J Gen Med       Date:  2020-12-03

Review 3.  The Role of the Oral Immune System in Oropharyngeal Candidiasis-Facilitated Invasion and Dissemination of Staphylococcus aureus.

Authors:  Raymond Pasman; Bastiaan P Krom; Sebastian A J Zaat; Stanley Brul
Journal:  Front Oral Health       Date:  2022-04-07

4.  Dynamics in perioperative neutrophil-to-lymphocyte*platelet ratio as a predictor of early acute kidney injury following cardiovascular surgery.

Authors:  Yang Li; Zhouping Zou; Yunlu Zhang; Bowen Zhu; Yichun Ning; Bo Shen; Chunsheng Wang; Zhe Luo; Jiarui Xu; Xiaoqiang Ding
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.